Recent News
View All
November 6, 2025
Entrada Therapeutics Reports Third Quarter 2025 Financial Results
October 28, 2025
Entrada Therapeutics to Present at Upcoming Investor Conferences
Our Mission
At Entrada, we are united in our mission to treat devastating diseases with intracellular therapeutics.
Our Platform
Our proprietary EEV™ Platform has the potential to reach and engage previously inaccessible and undruggable disease-causing targets within cells.
Our Pipeline
Our EEV™ Platform is highly versatile and modular, offering broad potential across therapeutic areas. We are already developing potential treatments spanning discovery to clinical-stage across multiple devastating diseases, and this is just the beginning.
Life at Entrada
Join our team if you share our values, relentless devotion to patients and passion for science.
